Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Prostate Cancer News ••• Topics • Countries • U.S. States

Prostate Cancer Statistics News Monitoring

Get by Email • RSS

Published on Jun 4, 2025

Darolutamide Gains FDA Approval for Metastatic Castration-Sensitive Prostate Cancer

The FDA has approved darolutamide (Nubeqa; Bayer Healthcare Pharmaceuticals) for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC), expanding its use beyond previously approved indications.1 This approval is supported …

Source: The American Journal of Managed Care - Neutral
Published on Jun 3, 2025

Adding CAN-2409 to radiation significantly extends DFS in localized prostate cancer

Adding aglatimagene besadenovec (CAN-2409) to standard of care (SOC) external beam radiation (EBRT) with or without androgen deprivation therapy (ADT) led to a statistically significant improvement in disease-free survival (DFS) vs EBRT alone in patients …

Source: Urology Times - Pending
Published on Jun 3, 2025

FDA OKs Darolutamide in Metastatic Castration-Sensitive Prostate Cancer

The FDA has approved darolutamide (Nubeqa) in the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC), according to a press release from the FDA.1 Previously, the FDA approved darolutamide combined with docetaxel in mCSPC.2 …

Source: Cancer Network - New Jersey - Pending
Published on Jun 3, 2025

FDA Approves Darolutamide in Metastatic Castration-Sensitive Prostate Cancer

The FDA has approved darolutamide (Nubeqa) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC). The approval is supported by the phase 3 ARANOTE trial (NCT02799602). The ARASENS trial (NCT02799602) previously supported the approval …

Source: Targeted Oncology - Pending
Published on Jun 3, 2025

Olaparib/Radium-223 Combo Boosts rPFS in Castration-Resistant Prostate Cancer

The combination of olaparib (Lynparza) and radium-223 (Xofigo) demonstrated superior radiographic progression-free survival (rPFS) compared with the radiopharmaceutical alone in men with castration-resistant prostate cancer (CRPC), regardless of hormone …

Source: Targeted Oncology - Pending
Published on Jun 3, 2025

FDA Approves Nubeqa in Metastatic Castration-Sensitive Prostate Cancer

The United States Food and Drug Administration (FDA) approved Nubeqa (darolutamide) for the treatment of metastatic castration-sensitive prostate cancer, according to a news release from the FDA. Nubeqa significantly improved radiographic progression-free …

Source: Cure Today - Neutral
Published on Jun 3, 2025

U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer

ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer Darolutamide is the first and only in the U.S. and FDA-approved androgen receptor inhibitor ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on Jun 3, 2025

Niraparib/Abiraterone Is Effective for HRR+ Metastatic Castration-Sensitive Prostate Cancer

The addition of the PARP inhibitor niraparib to abiraterone acetate (Akeega) and prednisone (AAP) reduced the risk of radiographic progression or death by 37% compared with AAP and placebo for patients with metastatic castration-sensitive prostate cancer ( …

Source: OncLive - Pending
Published on Jun 3, 2025

Akeega Combo Delays Progression in HRR+ Castration-Sensitive Prostate Cancer

A 37% reduction in the risk of radiographic progression or death was observed with the addition of the PARP inhibitor Akeega (niraparib) to Zytiga (abiraterone acetate) and prednisone (AAP), compared with AAP and placebo, in patients with metastatic …

Source: Cure Today - Neutral
Published on Jun 3, 2025

ASCO: J&J's Akeega gives PARP a novel prostate cancer win, but FDA path in patient subset unclear

The FDA has already approved PARP inhibitors in certain patients with metastatic castration-resistant prostate cancer (mCRPC). Now, Johnson & Johnson’s Akeega is giving the class a win in castration-sensitive disease, although the drug’s benefit in a …

Source: Fierce Pharma - Neutral
Published on Jun 3, 2025

Failure to screen Biden for prostate cancer was inexcusable

By Navin C. Shah, MD Dr. Navin C. Shah It is with great sorrow that I learned of former President Joe Biden’s diagnosis of advanced, aggressive prostate cancer with bone metastasis. As a physician who has spent decades treating and studying this disease, I …

Source: The American Bazaar - Center-left
Published on Jun 2, 2025

'Real Housewives of Atlanta' star Dwight Eubanks shares prostate cancer diagnosis

Dwight Eubanks attends 35th annual A Meal To Remember fundraising gala presented by Meals On Wheels Atlanta at Flourish Atlanta on November 3, 2023 in Atlanta, Georgia. (Photo by Paras Griffin/Getty Images) ATLANTA - "Real Housewives of Atlanta…

Source: FOX 5 Atlanta - Georgia - Indeterminate
Published on Jun 2, 2025

Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-...

Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition trial met its primary endpoint showing statistically significant and clinically meaningful benefit for Pluvicto™ plus hormone therapy versus hormone therapy alone, with positive …

Source: Business Upturn - Neutral
Published on Jun 2, 2025

June is Men's Health Month: Let's talk about living with prostate cancer

Statistics published by the American Cancer Society in 2025 suggest that one of every eight men (12.5%) will experience prostate cancer during their lifetime. And the incidence rate has increased by 3% each year since 2014. Men who are 65 and older are …

Source: Senior Voice - Alaska - Neutral
Published on 08:14 GMT

Rising cancer and heart disease cases drive R6. 62 Billion payout by one of South Africa’s largest insurers

Cancer, heart disease, and other lifestyle-related conditions contributed to a significant increase in insurance claims in 2024, with Sanlam Risk and Savings paying out R6.62 billion up 9.24% from the previous year. According to the company, the latest …

Source: IOL - Indeterminate
Published on 07:14 GMT

Johnson & Johnson's Akeega from AMPLITUDE study shows improved efficacy in patients with HRR─mutated mHSPC

Johnson & Johnson announced first results from the phase 3, randomised, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus prednisone (AAP) in patients with metastatic hormone-sensitive …

Source: Pharmabiz.com - Neutral
Published on 07:02 GMT

NHS doctor's five step health MOT all men should carry out to 'avoid dying before retirement'

Every 12 months, your motor needs an MOT to check it's roadworthy and everything is in full working order. And although you're car might be your pride and joy, it's not more important than the vehicle which gets you through life - your body. It …

Source: LAD Bible - Pending
Published on 01:44 GMT

Dr Saad on the FDA Approval of Darolutamide in mCSPC

“The [ARANOTE] study clearly met its primary end point of improving radiographic progression-free survival, [with] a 46% reduction in the risk of progression of metastatic sites. That was very statistically significant, and all the other secondary end …

Source: OncLive - Pending
Published on Jun 3, 2025

Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA─...

Novartis announced topline results from a pre-specified interim analysis of the phase III PSMAddition trial. The trial met its primary endpoint with a statistically significant and clinically meaningful benefit in radiographic progression-free survival ( …

Source: Pharmabiz.com - Neutral

days

hours

minutes

seconds

Featured Releases

Got News to Share? · Submit · See All

Published on June 4, 2025 - 12:30 GMT

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced ...

- Gadolinium-160 is a critical precursor isotope for producing Terbium-161, an emerging medical isotope with significant potential in targeted radiotherapies. - Supply agreement is for four years’ supply of enriched Gd-160, commencing in 2026, with an …

Distribution channels: Business & Economy, Chemical Industry ...
Published on June 3, 2025 - 22:18 GMT

New NIST Standard Helps Deliver the Right Dosage of Cancer-Fighting Drugs

Actinium-225 and some other radioactive elements that emit alpha rays can be transformed into cancer-fighting missiles if they are attached to molecules that seek out and attach to tumor cells. Because alpha rays dump most of their energy within extremely …

Distribution channels: Technology

Published on June 3, 2025 - 06:16 GMT

Scientists develop AI method to predict overall survival rate of prostate cancer patients

AI tools can provide close to precise survival estimates of patients with prostate cancer, according to scientists SHARJAH, UNITED ARAB EMIRATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Scientists say they have worked out a machine learning method …

Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
Published on June 3, 2025 - 20:30 GMT

U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer

ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer Darolutamide is the first and only in the U.S. and FDA-approved androgen receptor inhibitor ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 2, 2025 - 12:30 GMT

Syncromune® Inc. Presents Positive Results from SYNC-T® Therapy SV-102 Phase 1 Metastatic Prostate Cancer Trial at ASCO ...

Presentation highlights deep and durable responses and radiographic resolution of bone metastases in patients with advanced prostate cancer Final clinical data demonstrate an 87% overall response rate in patients with metastatic prostate cancer Results …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on June 4, 2025 - 14:00 GMT

Biomarker Market is expected to generate a revenue of USD 130.16 Billion by 2032, Globally, at 13.77% CAGR: Verified ...

Lewes, Delaware, June 04, 2025 (GLOBE NEWSWIRE) -- The Global Biomarker Market Size is projected to grow at a CAGR of 13.77% from 2026 to 2032, according to a new report published by Verified Market Research®. The report reveals that the market was valued …

Distribution channels: Business & Economy, Media, Advertising & PR ...
Published on May 31, 2025 - 12:00 GMT

Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated incidence and mortality in a high-risk population Data …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on June 3, 2025 - 13:36 GMT

New Collaboration Between Psifas and OpenDNA: Predicting Common Diseases Through AI and Genomic Data

HAIFA, ISRAEL, ISRAEL, June 3, 2025 /⁨EINPresswire.com⁩/ -- The Israeli National Initiative for Personalized Medicine, Psifas, and OpenDNA a Genomic AI biotech company have announced a strategic collaboration to develop artificial intelligence …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more prostate cancer news or search news using your own keywords. There are 819,276,923 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Prostate Cancer News by Country

Prostate Cancer News by U.S. State

Prostate Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 5, 2025 - 09:21 GMT

Vistatec Appoints John Berning as Strategic Account Manager

DUBLIN, IRELAND, June 5, 2025 /⁨EINPresswire.com⁩/ -- Vistatec, a leading global provider of content solutions and localization services, is pleased to announce the appointment of John Berning as Strategic Account Manager. John brings a uniquely global …

Distribution channels: Business & Economy, Companies ...
Published on June 5, 2025 - 08:55 GMT

Graphy Clears Preliminary Review for KOSDAQ Tech IPO — Draws Attention from Global Investors

– Targeting IPO in August 2025 with a post-IPO valuation of KRW 155 billion (approx. USD 110 million) MIAMI, FL, UNITED STATES, June 5, 2025 /⁨EINPresswire.com⁩/ -- Graphy Clears Preliminary Review for KOSDAQ Tech IPO — Draws Attention from Global …

Distribution channels: Beauty & Hair Care, Chemical Industry ...
Published on June 5, 2025 - 08:30 GMT

Rapid testing for sexually transmitted infections on the horizon

While current tests may be easy to use with minimal training, existing technologies have been unable to meet the target of 20 minutes from sample to results. BIRMINGHAM, UNITED KINGDOM, June 5, 2025 /⁨EINPresswire.com⁩/ -- Birmingham spin-out …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
Published on June 5, 2025 - 08:30 GMT

Cytology Fixatives Market to Reach USD 607.2 Million by 2035

From Smears to LBC: Evolution of the Cytology Fixatives Market NEW YORK, DE, UNITED STATES, June 5, 2025 /⁨EINPresswire.com⁩/ -- The global cytology fixatives market is projected to grow from USD 402.4 million in 2025 to USD 607.2 million by 2035, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 5, 2025 - 08:24 GMT

Ace Therapeutics Releases Custom Models to Empower Alzheimer's Disease Research

Ace Therapeutics has unveiled a suite of customizable in vivo and in vitro models designed to accelerate Alzheimer's disease (AD) drug development. NEW YORK, NY, UNITED STATES, June 5, 2025 /⁨EINPresswire.com⁩/ -- Ace Therapeutics, a leading …

Distribution channels: Business & Economy, Companies ...
Published on June 5, 2025 - 07:53 GMT

Top Growth Driver in the Fluid Management Systems Market 2025: Rising Demand For Less Invasive Procedures

The Business Research Company's Fluid Management Systems Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 5, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’ …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 5, 2025 - 07:39 GMT

Healthcare Buildings Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034

The Business Research Company's Healthcare Buildings Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 5, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 5, 2025 - 07:33 GMT

Comprehensive Insights Of The Global HER2 Inhibitors Market: Key Drivers, Trends, Growth, And Forecast For 2025-2034

The Business Research Company's HER2 Inhibitors Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 5, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Latest …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 5, 2025 - 07:31 GMT

7,000 nurses from 130 countries to convene for the International Council of Nurses Congress 2025 in Helsinki

Despite the global challenges nurses are facing, thousands are gathering to share their experiences under Congress theme, Nursing Power to Change the World. HELSINKI, GENEVA, SWITZERLAND, June 5, 2025 /⁨EINPresswire.com⁩/ -- 7,000 nurses from …

Distribution channels: Environment, Healthcare & Pharmaceuticals Industry ...
Published on June 5, 2025 - 06:36 GMT

Kalkine Introduces Mobile App Update with Improved Tools for Market Analysis

A Smarter, Sharper Financial Market Research Experience Now Live for Subscribers SYDNEY, NEW SOUTH WALES, AUSTRALIA, June 5, 2025 /⁨EINPresswire.com⁩/ -- Kalkine is proud to announce the launch of its newly upgraded Kalkine Subscription App, ( iOS …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on June 5, 2025 - 06:21 GMT

SPECTRA APPLIES VARIABLE DATA PRINTING TO ESTATE PLANNING

Spectra assists estate planning providers by providing streamlined variable data printing services. COLUMBIA, SC, UNITED STATES, June 5, 2025 /⁨EINPresswire.com⁩/ -- Variable data printing (VDP), a technique widely used in direct mail marketing, …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on June 5, 2025 - 06:08 GMT

Global Surgical Drill Bits Market 2025-2032 Now Offered by Market Research Center

Rising Demand for Precision Surgeries Fuels 5.2% CAGR in Global Surgical Drill Bits Market Through 2032 TOKYO, JAPAN, June 5, 2025 /⁨EINPresswire.com⁩/ -- The global surgical drill bits market is projected to expand steadily over the forecast …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...
Published on June 5, 2025 - 05:30 GMT

Axillary Hyperhidrosis Treatment Market to Surpass USD 3.42 Billion by 2035 at 6.0% CAGR

Growing Awareness Drives Axillary Hyperhidrosis Treatment Market to USD 3.42 Billion by 2035 NEW YORK, DE, UNITED STATES, June 5, 2025 /⁨EINPresswire.com⁩/ -- Global sales of axillary hyperhidrosis treatment reached approximately USD 1.91 billion …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 5, 2025 - 04:00 GMT

Atherosclerosis Market to Reach USD 62.2 Billion by 2035, Growing at 2.7% CAGR

Atherosclerosis Market Forecasted to Expand from USD 47.6 Billion in 2025 to USD 62.2 Billion by 2035 NEW YORK, DE, UNITED STATES, June 5, 2025 /⁨EINPresswire.com⁩/ -- The global atherosclerosis market is projected to grow from USD 47.6 billion in …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 5, 2025 - 02:30 GMT

Fertility Pregnancy Rapid Test Kits Market Set to Expand from USD 1.60 Billion in 2025 to USD 2.49 Billion by 2035

Fertility & Pregnancy Rapid Test Kits Market to Reach USD 2.49 Billion by 2035 at 4.5% CAGR NEW YORK, DE, UNITED STATES, June 5, 2025 /⁨EINPresswire.com⁩/ -- The fertility pregnancy rapid test kits market is expected to witness stable growth, with …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 4, 2025 - 23:18 GMT

U.S. House Passes FASD Authorization in the Support Act: Legislation Will Deliver Support to Individuals with FASD

Historic Congressional action marks milestone in FASD policy and moves community closer to achieving comprehensive Federal response to FASD WASHINGTON, DC, DC, UNITED STATES, June 4, 2025 /⁨EINPresswire.com⁩/ -- Today marks a milestone in Fetal …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on June 4, 2025 - 22:57 GMT

ACRM Urges Continued Federal Support for NIDILRR and Disability Research

RESTON, VA, UNITED STATES, June 4, 2025 /⁨EINPresswire.com⁩/ -- The American Congress of Rehabilitation Medicine (ACRM) has released a public statement urging renewed federal commitment to the National Institute on Disability, Independent Living …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 4, 2025 - 22:22 GMT

Pine Point Medical Expands Travel Vaccine Program to Support Safer Global Adventures

New offerings include Yellow Fever, Malaria prevention, and expert travel health advice to ensure safer global journeys for all travelers. LANSING, NY, UNITED STATES, June 4, 2025 /⁨EINPresswire.com⁩/ -- Pine Point Medical is proud to announce the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 4, 2025 - 21:56 GMT

Legal, Local, and Accessible: Love Bud and Kind Meds AZ Expand Safe Delivery Across Arizona

Kind Meds AZ expands access with fully compliant home delivery, improving safety, convenience, and patient care. PHOENIX, AZ, UNITED STATES, June 4, 2025 /⁨EINPresswire.com⁩/ -- In response to evolving cannabis legislation and increasing demand …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on June 4, 2025 - 21:24 GMT

Dr. Sandra R. Hernández Receives 2025 UCSF Healthcare Impact Award

UCSF Rosenman Institute honors a pioneering leader whose life’s work has reshaped healthcare in California SAN FRANCISCO, CA, UNITED STATES, June 4, 2025 /⁨EINPresswire.com⁩/ -- At the 2025 Rosenman Symposium, the UCSF Rosenman Institute proudly …

Distribution channels: Business & Economy, Conferences & Trade Fairs ...